IP Library Patent Application 13063156
Patent Application
App. No. 13/063,156

miRNA TARGETS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/063,156
Abstract

The present invention provides systems for identifying, isolating, and/or characterizing targets of micro RNAs.

Claims (13)

1 . A method comprising steps of:

providing a cell that contains an miRNA of interest; and

identifying one or more RNAs that interact with the miRNA in the cell.

2 . The method of claim 1 , wherein the step of identifying comprises isolating miRNA-RNA complexes.

3 . The method of claim 1 , wherein the miRNA is miR-24.

4 . The method of claim 1 , wherein the step of identifying comprises determining that the one or more interacting RNAs is enriched in miRNA-RNA complexes as compared with its cellular expression level.

5 . The method of claim 1 , further comprising a step of:

analyzing the one or more interacting RNAs by a technique selected from the group consisting of: reverse transcription (RT), polymerase chain reaction (PCR), sequence analysis, expression level analysis, network analysis, and combinations thereof.

6 . A target RNA identified according to the method of claim 1 .

7 . A kit comprising components for performing the method of claim 1 .

8 . The kit of claim 6 , comprising one or more components selected from the group consisting of: nucleic acid standards, reagents for labeling miRNAs, reagents for quantifying degree of target RNA enrichment relative to cellular expression levels, and combinations thereof.

9 . The kit of claim 6 , which kit further contains one or more components selected from the group consisting of: nucleic acid polymerases, nucleotides, nucleotide analogs, buffers, antibodies, labels, and combinations thereof.

10 . The kit of claim 6 , which kit further contains one or more components that regulate the concentration or the downstream effects of the one or more interacting RNAs.

Assignments (2)
MERGER Recorded Apr 23, 2013
From: IMMUNE DISEASE INSTITUTE, INC.
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 030263/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2011
From: LIEBERMAN, JUDY; LAL, ASHISH
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 026114/0274 →